Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|July 14, 2026
Response-adapted perioperative therapy for resectable esophageal cancer in the immunotherapy era: a narrative reviewYuyang Yan, Jiahua Lyu, Yungchang Chen, et al.
Scientific Reports|August 20, 2025
Predictive value of myosteatosis and subcutaneous adipose tissue on the prognosis of ESCC patients undergoing chemoradiotherapyLing Xiao, Yudi Liu, Xue Zhang, et al.
Oncotargets and Therapy|December 10, 2021
Efficacy and Drug Resistance Analysis of ALK Inhibitors in Combination with Stereotactic Body Radiation Therapy for Treating Lung Squamous Carcinoma Patient Harboring EML4-ALK RearrangementLong Liang, Mian Mao, Lei Wu, et al.
BMC Cancer|July 18, 2024
Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapyLing Xiao, Yudi Liu, Xue Zhang, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 25, 2024
Prognostic value of sarcopenia and myosteatosis alterations on survival outcomes for esophageal squamous cell carcinoma before and after radiotherapyNingjing Yang, Peng Zhou, Jiahua Lyu, et al.
Future Science OA|March 7, 2022
The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapyLing Xiao, Jiahua Lyu, Meihua Chen, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|May 21, 2014
[Evaluation of endoscopy assisted vitrectomy for the treatment of severe traumatic eyes with no light perception]Hui Ren, Rui Jiang, Gezhi Xu, et al.
Radiation Oncology (London, England)|November 28, 2018
Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled studyJiahua Lyu, Tao Li, Qifeng Wang, et al.
Nutrition and Cancer|October 12, 2020
Clinical Application Value of the Prognostic Nutritional Index for Predicting Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy or RadiotherapyLing Xiao, Jiahua Lyu, Xiao Liu, et al.
Journal of Pharmaceutical Analysis|January 4, 2024
Ginsenoside Rg5 enhances the radiosensitivity of lung adenocarcinoma via reducing HSP90-CDC37 interaction and promoting client protein degradationHansong Bai, Jiahua Lyu, Xinyu Nie, et al.
Pageof 2